98%
921
2 minutes
20
Objectives: Early sarcopenia detection using screening tools, such as SARC-F and SARC-CalF, has been proven reliable. However, the relationship between chronic musculoskeletal pain with sarcopenia is unknown. This study assessed sarcopenia morbidity as well as the reliability of sarcopenia screening with SARC-F and SARC-CalF in patients with chronic musculoskeletal pain.
Methods: Overall, 172 patients with chronic musculoskeletal pain were included in this cross-sectional study. All participants completed the SARC-F, SARC-CalF, numeric rating scale (NRS), and pain disability assessment scale (PDAS) assessments. Sarcopenia was diagnosed using the Asian Working Group for Sarcopenia criteria 2019. Correlations between SARC-F and SARC-CalF scores and each measured variable were evaluated using univariate and multiple linear regression analyses. A receiver operating characteristic curve analysis was conducted, and reliabilities of SARC-F and SARC-CalF scores for diagnosing sarcopenia were compared.
Results: Thirty-nine patients were diagnosed with sarcopenia. Among these, 10 patients were <65 years old, and 29 were >65 years old. Both SARC-F and SARC-CalF scores significantly correlated with grip power, gait speed, skeletal mass index, numeric rating scale score, and PDAS score. In multiple linear regression analysis, SALC-F and SALC-CalF scores significantly correlated with PDAS score, skeletal mass index, and gait speed. The area under the curve were 0.70 for SARC-F and 0.88 for SARC-CalF; SARC-CalF had a significantly higher area under the curve than SARC-F.
Discussion: Sarcopenia was diagnosed in patients aged <65 years with chronic musculoskeletal pain. SALC-F and SARC-CalF scores showed a significant correlation with disability due to pain and were reliable sarcopenia screening tools for chronic musculoskeletal pain. SARC-CalF was more reliable than SARC-F.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302257 | PMC |
http://dx.doi.org/10.1097/MD.0000000000029568 | DOI Listing |
Front Nutr
August 2025
Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Background: Sarcopenia screening in bone tumor patients is challenging due to limited awareness, complex procedures, and high costs-especially since most research targets older adults, overlooking younger patients in this group. This study aims to compare the screening efficacy of five different tools for sarcopenia, and to identify the most appropriate screening tool for patients with bone tumors.
Methods: The five sarcopenia screening tools assessed were SARC-F, SARC-Calf, SARC-F + EBM, and the Chinese versions of the Mini-Sarcopenia Risk Assessment scales (MSRA-5 and MSRA-7).
Objectives: This study aimed to assess the diagnostic value of the SARC-F and its two modified versions, SARC-F EBM and SARCCalF.
Material And Methods: This prospective observational study included 468 participants aged ≥ 65 years. The diagnostic tools assessed were the SARC-F, SARC-F EBM, and SARCCalF.
Eur Geriatr Med
June 2025
Department of Biomedical Sciences, University of Padova, Padua, Italy.
Purpose: This study aims to identify key risk factors for sarcopenia using machine learning models, leveraging anthropometric, biochemical, functional, nutritional, and genetic data. By developing predictive models, the research seeks to improve early detection, enhance diagnostic accuracy, and facilitate personalized interventions for individuals at risk of sarcopenia.
Methods: We analysed multimodal data from 484 older adults.
J Am Med Dir Assoc
August 2025
Department of Orthopaedic Surgery, National Taiwan University Hospital, Taipei City, Taiwan; Department of Orthopedics, National Taiwan University Hospital Yun-Lin Branch, Douliu City, Yunlin County, Taiwan. Electronic address:
Objectives: Sarcopenia is a serious condition in older individuals, characterized by muscle loss and physical decline. Early detection is crucial but challenging due to subtle symptoms. The Asian Working Group for Sarcopenia (AWGS) 2019 consensus recommends detection for possible sarcopenia, but the effectiveness of the suggested tools varies, and the ideal screening combination remains unclear.
View Article and Find Full Text PDFBMC Geriatr
May 2025
Clinical Research Unit, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Background: Most diagnostic studies on sarcopenia in Asia follow the 2019 Asian Working Group for Sarcopenia (AWGS) guidelines, which recommend distinct diagnostic strategies for community and hospital settings due to challenges in measuring muscle mass in community environments. This study evaluates the screening-to-diagnosis process in community-based preventive services.
Methods: This cross-sectional study utilized a questionnaire survey to evaluate SARC-F and SARC-CalF.